CheckMyRecalls

Medicines & drugs recalls

909 recalls since January 2025 from Health Canada, FDA, newest first. Last notice 19 Nov 2026.

Page 19 of 19

  1. JAMP-Escitalopram: may contain blisters of the foreign product Tillomed Gabapentin 100mg capsuleHealth CanadaProduct quality
  2. QUETIAPINE XR : Affected lots may exceed the established acceptable intake limit for N-nitroso-desalkyl-quetiapine (NNAP)Health CanadaProduct quality
  3. MXBBB recalls UMARY ACID HYALURONICFDACGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and…
  4. Curium US, LLC recalls Kit for the Preparation of Technetium Tc 99m Sestamibi InjectionFDALack of Assurance of Sterility; Improper crimps on vials impacting the integrity of the product
  5. Breckenridge Pharmaceutical, Inc recalls Duloxetine Delayed-Release CapsulesFDACGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
  6. RemedyRepack Inc. recalls Duloxetine Delayed-Release CapsulesFDACGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.
  7. PD-Rx Pharmaceuticals, Inc. recalls DULoxetine DR USPFDACGMP Deviations: the presence of a Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Duloxetine above the interim acceptable intake limit
  8. Glenmark Pharmaceuticals Inc., USA recalls chlorproMAZINE Hydrochloride TabletsFDACGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.
  9. Amerisource Health Services LLC recalls Duloxetine Delayed-Release Capsules and 1 moreFDACGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.